VRTX
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Call dated Feb. 12, 2026 Corporate Participants: Susie Lisa — Senior Vice…
Vertex Pharmaceuticals Incorporated (VRTX) Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Other Release
Vertex Pharmaceuticals Incorporated (VRTX) Barclays 28th Annual Global Healthcare Conference
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Corporate Conference
Vertex Pharmaceuticals Incorporated (VRTX) Leerink Global Healthcare Conference
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Corporate Conference
Vertex Pharmaceuticals Incorporated (VRTX) Vertex to Present New Data on JOURNAVX That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Other Release
Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 46th Annual Health Care Conference
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Corporate Conference
Vertex Pharmaceuticals Incorporated (VRTX) Sec Form 10K
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 10K
Vertex Pharmaceuticals Incorporated (VRTX) Sec Form 8K
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 8K
Vertex Pharma Q4 2025 Earnings Results
Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis…
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Results
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Release